...
首页> 外文期刊>Bulletin of the Korean Chemical Society >Crystal Structure and Tautomerism Study of the Mono-protonated Metformin Salt
【24h】

Crystal Structure and Tautomerism Study of the Mono-protonated Metformin Salt

机译:单质子化二甲双胍盐的晶体结构和互变异构研究

获取原文
获取原文并翻译 | 示例
           

摘要

A novel crystal, the mono-protonated metformin acetate (1), was obtained and characterized by elemental analysis, IR spectroscopy and X-ray crystallography. It was found that one of the imino group in the metformin cation was protonated along with the proton transfer from the secondary amino group to the other imino group. Its crystal structure was then compared with the previously reported diprotonated metformin oxalate (2). The difference between them is that the mono-protonated metformin cations can be linked by hydrogen bonding to form dimers while the diprotonated metformin cations cannot. Both of them are stabilized by intermolecular hydrogen bonds to assemble a 3-D supermolecular structure. The four potential tautomer of the mono-protonated metformin cation (tautomers 1a, 1b, 1c and 1d) were optimized and their single point energies were calculated by Density Functional Theory (DFT) B3LYP method based on the Polarized Continuum Model (PCM) in water, which shows that the most likely existed tautomer in human cells is the same in the crystal structure. Based on the optimized structure, their Wiberg bond orders, Natural Population Analysis (NPA) atomic charges, molecular electrostatic potential (MEP) maps were calculated to analyze their electronic structures, which were then compared with the corresponding values of the diprotonated metformin cation (cation 2) and the neutral metformin (compound 3). Finally, the possible tautomeric mechanism of the monoprotonated metformin cation was discussed based on the observed phenomena.
机译:获得了一种新型晶体,即单质子化的乙酸二甲双胍(1),并通过元素分析,红外光谱和X射线晶体学进行了表征。发现二甲双胍阳离子中的一个亚氨基基团与质子从仲氨基转移到另一个亚氨基基团一起被质子化。然后将其晶体结构与先前报道的二质子化草酸二甲双胍进行比较(2)。它们之间的区别在于,单质子化的二甲双胍阳离子可以通过氢键连接形成二聚体,而双质子化的二甲双胍阳离子则不能。它们两者都通过分子间氢键稳定以组装3-D超分子结构。优化了单质子化二甲双胍阳离子的四个潜在互变异构体(互变异构体1a,1b,1c和1d),并基于极化连续谱模型(PCM)通过密度泛函理论(DFT)B3LYP方法计算了它们的单点能量,这表明人类细胞中最可能存在的互变异构体的晶体结构相同。基于优化的结构,计算其Wiberg键阶,自然种群分析(NPA)原子电荷,分子静电势(MEP)谱图以分析其电子结构,然后将其与双质子化二甲双胍阳离子(阳离子)的相应值进行比较2)和中性二甲双胍(化合物3)。最后,根据观察到的现象讨论了单质子化二甲双胍阳离子可能的互变异构机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号